Meningitis Vaccine News and Research

RSS

Nigeria first to rollout new Men5CV vaccine against meningitis

In a historic move, Nigeria has become the first country in the world to roll out a new vaccine (called Men5CV) recommended by the World Health Organization (WHO), which protects people against five strains of the meningococcus bacteria.

15 Apr 2024

New meningitis vaccine safe and effective for infants in Africa

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.

3 Oct 2023

Novel vaccine offers hope for defeating epidemic meningitis by 2030

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal bacteria: A, C, W, Y and X.

25 May 2023

Bacteria exploit nerve cells in the meninges to facilitate brain invasion

A new study led by researchers at Harvard Medical School details the step-by-step cascade that allows bacteria to break through the brain's protective layers -; the meninges -; and cause brain infection, or meningitis, a highly fatal disease.

1 Mar 2023

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

How to run a COVID-19 vaccination campaign: lessons from other infectious outbreaks

A new paper, available on the medRxiv* preprint server, presents lessons learned from the implementation of three adult vaccine programs in low- and middle-income countries (LMICs) in Africa and South America.

21 Jul 2021

World Immunization Week: Vaccination in 2021

News-Medical talks to experts in different areas of the medical sector on why immunization week is so prevalent in 2021.

27 Apr 2021

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Promising early stage results from a phase 1/2 clinical trial of the UK's vaccine candidate against SARS-CoV-2 (the virus that causes COVID-19) are published today in The Lancet.

20 Jul 2020

What parents need to know about the HPV vaccine

The vaccine that prevents infection from human papillomavirus (HPV) is nothing short of a medical marvel.

28 Jan 2020

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017

Parents may be less sure about vaccine needs for teens, new poll suggests

Parents may be up to speed on what vaccines their children need for kindergarten, but may be less sure during high school years, a new national poll suggests.

17 Jul 2017

GSK launches educational campaign to help raise awareness of meningitis

GSK today launched an educational campaign to help raise awareness of meningitis, a rare but potentially deadly disease.

8 Aug 2016

Maternal vaccination against influenza can reduce flu risk in newborns

Each year, influenza causes between 250,000 and half a million deaths around the world. Pregnant women and young infants have a higher risk of complications related to influenza; these complications can easily lead to death.

3 Jun 2016

Experts available to discuss use of meningitis vaccine in childhood immunization programs

Global vaccine experts and officials from all 26 African "meningitis belt" countries will convene in Ethiopia next week in advance of the Ministerial Conference on Immunization to celebrate one of Africa's biggest public health achievements--the introduction of a vaccine that in five years of use has protected more than 235 million people in 16 countries, nearly eliminating meningitis A disease on the continent.

17 Feb 2016

Adverse events linked with HPV vaccine appear to be related with media coverage

The number of adverse events associated with the HPV vaccine reported to the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) appeared to be related to media coverage and online controversy about the vaccine, finds a study in the Journal of Adolescent Health.

20 Nov 2013

Study evaluates effectiveness of new meningitis serogroup A vaccine in sub-Saharan Africa

Evaluation of the effectiveness of a mass vaccination campaign with a new meningitis serogroup A vaccine, PsA-TT, in sub-Saharan Africa found that it had a dramatic impact on cases of serogroup meningitis and on carriage of the disease-causing bacteria in the throat, according to new research published in The Lancet.

13 Sep 2013

MenAfriVac reduces incidence of meningitis by 94%

A new meningitis vaccine (MenAfriVac) is highly effective at protecting against epidemic A meningococcal disease, common in Africa’s meningitis belt where it accounts for at least three quarters of cases, and against transmission of the bacterium that causes these epidemics, according to new research published in The Lancet.

13 Sep 2013

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

Dropping of cold chain requirement for meningitis vaccine will improve access, IRIN reports

IRIN examines how the WHO's recent declaration that the MenAfriVac meningitis A vaccine can be transported or stored for up to four days without refrigeration will affect immunization campaigns in Africa's meningitis belt, which runs from Senegal to Ethiopia.

22 Nov 2012

Meningitis vaccine declared usable without refrigeration for up to four days

"In a breakthrough for the fight against meningitis in poor countries, researchers say the WHO has ruled that a key vaccine can be transported or stored for up to four days without refrigeration," Agence France-Presse reports.

16 Nov 2012